Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

At the center of their discovery is a protein called S100A9, which has been shown to reduce dangerous levels of ketones in the blood—without relying on insulin. For people living with type 1 ...

Some recent research has suggested that type 2 diabetes and dementia may share some physiological similarities, including inflammation and impaired insulin signalling in the brain. People with ...

The first 10 drugs targeted for negotiations were announced the following year — Novo’s rapid-acting insulin medication NovoLog among them — and new prices, agreed upon in 2024, are set to take effect ...

The Michigan Supreme Court, after hearing oral arguments last year on the state attorney general’s desire to investigate Eli Lilly & Co.’s insulin pricing practices, will hold another round of ...

If the person with diabetes is unconscious or you don't know how to use glucagon, call 911. People with diabetes who take insulin should have a prescription for either injectable glucagon or inhaled ...

Glucagon and insulin, both hormones released by the pancreas, work together to help the body maintain healthy sugar levels. When sugar levels drop, glucagon levels increase, prompting the liver to ...

When working properly, your pancreas releases insulin to help cells absorb glucose from your bloodstream. Without enough insulin or when cells don’t respond to it properly, blood sugar levels ...

pennmedicine.upenn.edu Background/aims Glucagon-like peptide-1 receptor (GLP-1R) agonists regulate blood glucose and are commonly used to treat type 2 diabetes mellitus. Recent work showed that ...

Pacemakers. Insulin pumps. Hearing aids. These are just some of the basic medical devices that hospitals and patients rely on—and that could see higher prices due to President Trump’s tariffs.

Federal Trade Commission Chair Andrew Ferguson has reversed course on his decision to recuse himself from the agency's legal battle with pharmacy benefit managers. Ferguson said in a statement ...